{"id":"https://openalex.org/W2904596955","doi":"https://doi.org/10.1093/eurheartj/ehy677","title":"Addressing cardiovascular risk in type 2 diabetes mellitus: a report from the European Society of Cardiology Cardiovascular Roundtable","display_name":"Addressing cardiovascular risk in type 2 diabetes mellitus: a report from the European Society of Cardiology Cardiovascular Roundtable","alternate_titles":[],"publication_year":2018,"publication_date":"2018-11-16","ids":{"openalex":"https://openalex.org/W2904596955","doi":"https://doi.org/10.1093/eurheartj/ehy677","mag":"2904596955","pmid":"https://pubmed.ncbi.nlm.nih.gov/30445605"},"language":"en","primary_location":{"id":"doi:10.1093/eurheartj/ehy677","doi":"https://doi.org/10.1093/eurheartj/ehy677","is_oa":false,"landing_page_url":"https://doi.org/10.1093/eurheartj/ehy677","pdf_url":null,"source":{"id":"https://openalex.org/S181568219","display_name":"European Heart Journal","issn_l":"0195-668X","issn":["0195-668X","1522-9645"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Heart Journal","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2904596955"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070855397","display_name":"Francesco Cosentino","orcid":"https://orcid.org/0000-0002-6967-5685","observed_orcids":["https://orcid.org/0000-0002-6967-5685"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Francesco Cosentino","raw_affiliation_strings":["Karolinska Institute & Karolinska University Hospital Cardiology Unit, Department of Medicine Solna, , Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Karolinska Institute & Karolinska University Hospital Cardiology Unit, Department of Medicine Solna, , Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835","https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044764461","display_name":"Antonio Ceriello","orcid":"https://orcid.org/0000-0001-8122-3203","observed_orcids":["https://orcid.org/0000-0001-8122-3203"]},"institutions":[{"id":"https://openalex.org/I4210092133","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Diabetes y Enfermedades Metab\u00f3licas Asociadas","ror":"https://ror.org/00dwgct76","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210092133","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210094922","display_name":"MultiMedica","ror":"https://ror.org/01h8ey223","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210094922","https://openalex.org/I4210153126"]},{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]}],"countries":["ES","IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Antonio Ceriello","raw_affiliation_strings":["IRCCS MultiMedica Department of Cardiovascular and Metabolic Diseases, , Sesto San Giovanni, Italy","Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS) and Centro de Investigaci\u00f3n Biomedica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IRCCS MultiMedica Department of Cardiovascular and Metabolic Diseases, , Sesto San Giovanni, Italy","institution_ids":["https://openalex.org/I4210094922"]},{"raw_affiliation_string":"Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS) and Centro de Investigaci\u00f3n Biomedica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM), Barcelona, Spain","institution_ids":["https://openalex.org/I4210092133","https://openalex.org/I4210160192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112384687","display_name":"Florian M.M. Baeres","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Florian M M Baeres","raw_affiliation_strings":["Novo Nordisk A/S , S\u00f8borg, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S , S\u00f8borg, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066210400","display_name":"Paola Fioretto","orcid":"https://orcid.org/0000-0003-3445-0387","observed_orcids":["https://orcid.org/0000-0003-3445-0387"]},"institutions":[{"id":"https://openalex.org/I138689650","display_name":"University of Padua","ror":"https://ror.org/00240q980","country_code":"IT","type":"education","lineage":["https://openalex.org/I138689650"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paola Fioretto","raw_affiliation_strings":["University of Padova Department of Medicine, , Padova, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Padova Department of Medicine, , Padova, Italy","institution_ids":["https://openalex.org/I138689650"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111831506","display_name":"Alan J. Garber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alan Garber","raw_affiliation_strings":["Baylor College of Medicine , Houston, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor College of Medicine , Houston, Texas, USA","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028176511","display_name":"Wendy Gattis Stough","orcid":"https://orcid.org/0000-0001-8290-1205","observed_orcids":["https://orcid.org/0000-0001-8290-1205"]},"institutions":[{"id":"https://openalex.org/I132446568","display_name":"Campbell University","ror":"https://ror.org/00dv9q566","country_code":"US","type":"education","lineage":["https://openalex.org/I132446568"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wendy Gattis Stough","raw_affiliation_strings":["Campbell University College of Pharmacy and Health Sciences , Cary, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Campbell University College of Pharmacy and Health Sciences , Cary, North Carolina, USA","institution_ids":["https://openalex.org/I132446568"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034066967","display_name":"Jyothis Thomas George","orcid":"https://orcid.org/0000-0002-5299-775X","observed_orcids":["https://orcid.org/0000-0002-5299-775X"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jyothis T George","raw_affiliation_strings":["Boehringer Ingelheim International , Pharma GmbH & Co. KG, Ingelheim, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim International , Pharma GmbH & Co. KG, Ingelheim, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036249431","display_name":"Peter J. Grant","orcid":"https://orcid.org/0000-0001-8465-2919","observed_orcids":["https://orcid.org/0000-0001-8465-2919"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter J Grant","raw_affiliation_strings":["Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds , Leeds, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds , Leeds, UK","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083222970","display_name":"Kamlesh Khunti","orcid":"https://orcid.org/0000-0003-2343-7099","observed_orcids":["https://orcid.org/0000-0003-2343-7099"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kamlesh Khunti","raw_affiliation_strings":["Diabetes Research Centre , Leicester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes Research Centre , Leicester, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012551917","display_name":"Anna Maria Langkilde","orcid":"https://orcid.org/0000-0002-1696-9356","observed_orcids":["https://orcid.org/0000-0002-1696-9356"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anna Maria Langkilde","raw_affiliation_strings":["AstraZeneca , Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca , Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051351787","display_name":"Jorge Plutzky","orcid":"https://orcid.org/0000-0002-7194-9876","observed_orcids":["https://orcid.org/0000-0002-7194-9876"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jorge Plutzky","raw_affiliation_strings":["Brigham and Women\u2019s Hospital , Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women\u2019s Hospital , Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032244539","display_name":"Lars Ryd\u00e9n","orcid":"https://orcid.org/0000-0002-5430-4697","observed_orcids":["https://orcid.org/0000-0002-5430-4697","https://orcid.org/0000-0001-7350-9076"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lars Ryd\u00e9n","raw_affiliation_strings":["Department of Medicine, K2, Karolinska Institute , Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, K2, Karolinska Institute , Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039563874","display_name":"Andr\u00e9 Jacques Scheen","orcid":"https://orcid.org/0000-0001-9743-4371","observed_orcids":["https://orcid.org/0000-0001-9743-4371"]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]},{"id":"https://openalex.org/I4210134544","display_name":"Centre Hospitalier Universitaire de Li\u00e8ge","ror":"https://ror.org/044s61914","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210134544"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andr\u00e9 Scheen","raw_affiliation_strings":["University of Li\u00e8ge Division of Diabetes, Nutrition, and Metabolic Disorders, Division of Clinical Pharmacology, CHU de Li\u00e8ge, , Li\u00e8ge, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Li\u00e8ge Division of Diabetes, Nutrition, and Metabolic Disorders, Division of Clinical Pharmacology, CHU de Li\u00e8ge, , Li\u00e8ge, Belgium","institution_ids":["https://openalex.org/I157674565","https://openalex.org/I4210134544"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090174827","display_name":"Eberhard Standl","orcid":"https://orcid.org/0000-0002-8667-633X","observed_orcids":["https://orcid.org/0000-0002-8667-633X"]},"institutions":[{"id":"https://openalex.org/I3018134672","display_name":"Helmholtz Munich","ror":"https://ror.org/00cfam450","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I3018134672"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eberhard Standl","raw_affiliation_strings":["Forschergruppe Diabetes eV at Munich Helmholtz Centre , Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Forschergruppe Diabetes eV at Munich Helmholtz Centre , Munich, Germany","institution_ids":["https://openalex.org/I3018134672"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101494461","display_name":"Jaakko O. Tuomilehto","orcid":"https://orcid.org/0000-0002-3424-0745","observed_orcids":["https://orcid.org/0000-0002-3424-0745"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I185163786","display_name":"King Abdulaziz University","ror":"https://ror.org/02ma4wv74","country_code":"SA","type":"education","lineage":["https://openalex.org/I185163786"]},{"id":"https://openalex.org/I39624965","display_name":"Finnish Institute for Health and Welfare","ror":"https://ror.org/03tf0c761","country_code":"FI","type":"government","lineage":["https://openalex.org/I39624965"]}],"countries":["FI","SA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jaakko Tuomilehto","raw_affiliation_strings":["King Abdulaziz University Diabetes Research Group, , Jeddah, Saudi Arabia","National Institute for Health and Welfare Chronic Disease Prevention Unit, , Helsinki, Finland","University of Helsinki Department of Public Health, , Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"King Abdulaziz University Diabetes Research Group, , Jeddah, Saudi Arabia","institution_ids":["https://openalex.org/I185163786"]},{"raw_affiliation_string":"National Institute for Health and Welfare Chronic Disease Prevention Unit, , Helsinki, Finland","institution_ids":["https://openalex.org/I39624965"]},{"raw_affiliation_string":"University of Helsinki Department of Public Health, , Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036821495","display_name":"Faiez M. Zannad","orcid":"https://orcid.org/0000-0001-7456-1570","observed_orcids":["https://orcid.org/0000-0001-7456-1570"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210100260","display_name":"Centre Hospitalier R\u00e9gional et Universitaire de Nancy","ror":"https://ror.org/016ncsr12","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100260"]},{"id":"https://openalex.org/I4387155877","display_name":"D\u00e9faillance Cardiovasculaire Aigu\u00eb et Chronique","ror":"https://ror.org/05ft9wv42","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4387155877","https://openalex.org/I90183372"]},{"id":"https://openalex.org/I90183372","display_name":"Universit\u00e9 de Lorraine","ror":"https://ror.org/04vfs2w97","country_code":"FR","type":"education","lineage":["https://openalex.org/I90183372"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Faiez Zannad","raw_affiliation_strings":["Centre d\u2019Investigations Cliniques- 1433 Inserm, , and Inserm U1116, CHRU, Nancy, France","F-CRIN INI-CRCT , Nancy, France","Universit\u00e9 de Lorraine , Nancy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre d\u2019Investigations Cliniques- 1433 Inserm, , and Inserm U1116, CHRU, Nancy, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210100260","https://openalex.org/I4387155877"]},{"raw_affiliation_string":"F-CRIN INI-CRCT , Nancy, France","institution_ids":[]},{"raw_affiliation_string":"Universit\u00e9 de Lorraine , Nancy, France","institution_ids":["https://openalex.org/I90183372"]}]}],"institutions":[],"countries_distinct_count":11,"institutions_distinct_count":23,"corresponding_author_ids":["https://openalex.org/A5070855397"],"corresponding_institution_ids":["https://openalex.org/I1335113835","https://openalex.org/I28166907"],"apc_list":{"value":5240,"currency":"EUR","value_usd":5922},"apc_paid":null,"fwci":4.3153,"has_fulltext":false,"cited_by_count":50,"citation_normalized_percentile":{"value":0.95447583,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"40","issue":"34","first_page":"2907","last_page":"2919"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.9679999947547913},{"id":"https://openalex.org/keywords/cardiovascular-disease","display_name":"cardiovascular disease","score":0.6399999856948853},{"id":"https://openalex.org/keywords/cardioprotection","display_name":"cardioprotection","score":0.7630000114440918},{"id":"https://openalex.org/keywords/glucose-lowering-therapy","display_name":"glucose-lowering therapy","score":0.7820000052452087},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9599999785423279},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9089999794960022},{"id":"https://openalex.org/keywords/cardiovascular-outcome-trials","display_name":"cardiovascular outcome trials","score":0.7839999794960022},{"id":"https://openalex.org/keywords/cardiovascular-safety","display_name":"cardiovascular safety","score":0.5849999785423279},{"id":"https://openalex.org/keywords/treatment-gap","display_name":"treatment gap","score":0.4429999887943268},{"id":"https://openalex.org/keywords/cardiovascular-mortality","display_name":"cardiovascular mortality","score":0.47099998593330383},{"id":"https://openalex.org/keywords/cardiovascular-risk-stratification","display_name":"cardiovascular risk stratification","score":0.35899999737739563},{"id":"https://openalex.org/keywords/cardiovascular-risk-communication","display_name":"cardiovascular risk communication","score":0.3869999945163727},{"id":"https://openalex.org/keywords/cardiovascular-risk-education","display_name":"cardiovascular risk education","score":0.460999995470047}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9734266996383667},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.5922654867172241},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5878351926803589},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5427002310752869},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.4529031217098236},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.32136496901512146},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.0929945707321167}],"mesh":[{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003226","descriptor_name":"Congresses as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D033183","descriptor_name":"Interdisciplinary Communication","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048909","descriptor_name":"Diabetes Complications","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D048909","descriptor_name":"Diabetes Complications","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true}],"locations_count":7,"locations":[{"id":"doi:10.1093/eurheartj/ehy677","doi":"https://doi.org/10.1093/eurheartj/ehy677","is_oa":false,"landing_page_url":"https://doi.org/10.1093/eurheartj/ehy677","pdf_url":null,"source":{"id":"https://openalex.org/S181568219","display_name":"European Heart Journal","issn_l":"0195-668X","issn":["0195-668X","1522-9645"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Heart Journal","raw_type":"journal-article"},{"id":"pmid:30445605","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30445605","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European heart journal","raw_type":"Journal Article"},{"id":"pmh:oai:orbi.ulg.ac.be:2268/230406","doi":null,"is_oa":false,"landing_page_url":"https://orbi.uliege.be/handle/2268/230406","pdf_url":null,"source":{"id":"https://openalex.org/S4306401300","display_name":"ORBi (University of Li\u00e8ge)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I157674565","host_organization_name":"University of Li\u00e8ge","host_organization_lineage":["https://openalex.org/I157674565"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"European Heart Journal, 0, 1-13 (2019)","raw_type":"http://purl.org/coar/resource_type/c_6501"},{"id":"pmh:oai:www.julkari.fi:10024/138739","doi":null,"is_oa":false,"landing_page_url":"http://www.julkari.fi/handle/10024/138739","pdf_url":null,"source":{"id":"https://openalex.org/S4306402058","display_name":"STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"WOS","raw_type":"A1"},{"id":"pmh:oai:www.research.unipd.it:11577/3303146","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11577/3303146","pdf_url":null,"source":{"id":"https://openalex.org/S4306402547","display_name":"Padua Research Archive (University of Padova)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I138689650","host_organization_name":"University of Padua","host_organization_lineage":["https://openalex.org/I138689650"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:www.research.unipd.it:11577/3310922","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11577/3310922","pdf_url":null,"source":{"id":"https://openalex.org/S4306402547","display_name":"Padua Research Archive (University of Padova)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I138689650","host_organization_name":"University of Padua","host_organization_lineage":["https://openalex.org/I138689650"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:2982226618","doi":null,"is_oa":false,"landing_page_url":"https://www.julkari.fi/handle/10024/138739","pdf_url":null,"source":{"id":"https://openalex.org/S4306534972","display_name":"WOS","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"WOS","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":64,"referenced_works":["https://openalex.org/W1855278889","https://openalex.org/W1932640386","https://openalex.org/W1973714538","https://openalex.org/W1994082114","https://openalex.org/W2012117258","https://openalex.org/W2036246782","https://openalex.org/W2043807347","https://openalex.org/W2047131454","https://openalex.org/W2050160827","https://openalex.org/W2064130493","https://openalex.org/W2083342497","https://openalex.org/W2114978217","https://openalex.org/W2120822075","https://openalex.org/W2124234371","https://openalex.org/W2127125241","https://openalex.org/W2127854619","https://openalex.org/W2131490500","https://openalex.org/W2134453898","https://openalex.org/W2137097374","https://openalex.org/W2142830692","https://openalex.org/W2146264128","https://openalex.org/W2150561315","https://openalex.org/W2158106881","https://openalex.org/W2159969745","https://openalex.org/W2188846692","https://openalex.org/W2274836352","https://openalex.org/W2282578582","https://openalex.org/W2337454357","https://openalex.org/W2339857359","https://openalex.org/W2341757727","https://openalex.org/W2400230962","https://openalex.org/W2425644022","https://openalex.org/W2475001516","https://openalex.org/W2519510391","https://openalex.org/W2582061242","https://openalex.org/W2591995058","https://openalex.org/W2602058707","https://openalex.org/W2605922583","https://openalex.org/W2614137535","https://openalex.org/W2619754961","https://openalex.org/W2619881304","https://openalex.org/W2621101635","https://openalex.org/W2626446274","https://openalex.org/W2740802742","https://openalex.org/W2746874591","https://openalex.org/W2750917994","https://openalex.org/W2754041380","https://openalex.org/W2756152366","https://openalex.org/W2768451744","https://openalex.org/W2773880106","https://openalex.org/W2779223875","https://openalex.org/W2782920834","https://openalex.org/W2791011305","https://openalex.org/W2792839297","https://openalex.org/W2807941224","https://openalex.org/W2808467887","https://openalex.org/W2890465901","https://openalex.org/W2916996193","https://openalex.org/W2999223678","https://openalex.org/W3171237122","https://openalex.org/W4211172623","https://openalex.org/W4214911496","https://openalex.org/W4235892613","https://openalex.org/W4240449862"],"related_works":["https://openalex.org/W2572665339","https://openalex.org/W2968538916","https://openalex.org/W3187156605","https://openalex.org/W4235892613","https://openalex.org/W7015539491","https://openalex.org/W2922257867","https://openalex.org/W2920938798","https://openalex.org/W2161663340","https://openalex.org/W4297229419","https://openalex.org/W2725253864"],"abstract_inverted_index":{"Type":[0,1000,1854,2215,2851,3112],"2":[1,1001,1450,1855,2216,2852,3113],"diabetes":[2,31,83,116,266,476,1256,1752,2113,3000,3177,3182,3378,3526,3791,4104,4418],"mellitus":[3,267,3001,3379,3529],"(T2DM)":[4],"is":[5,143,169,515,769,1413,1558,1619,1666,1704,2487,3040,3129,3253,3464,3530,3642,3728,3876,3924,3954,4001,4008,4094,4100,4272,4287,4303,4366,4371,4497,4567,4668,4680,4687],"a":[6,16,132,203,446,516,536,548,672,771,852,1183,1324,1338,1366,1389,1410,1458,1478,1627,1634,1710,2077,2438,2505,2551,2571,2583,2819,2952,2973,2989,3147,3254,3283,3351,3363,3391,3531,3669,3793,3808,3851,3911,3933,3955,3989,3995,4026,4031,4101,4226,4273,4304,4363,4402,4516,4548,4568,4669],"recognized":[7],"risk":[8,201,229,309,448,727,792,936,1013,1222,1368,1480,1531,1585,1998,2007,2027,2359,2368,2388,2462,2482,2536,2913,3010,3108,3119,3204,3270,3302,3404,3462,3503,3533,3593,3795,3803,4087,4142,4194,4341,4426,4455],"factor":[9,3205,3534,3796],"for":[10,90,230,259,265,315,347,352,367,449,519,847,891,1010,1078,1106,1125,1199,1369,1443,1547,1604,1826,2187,2538,2576,2808,2839,2843,2860,2866,2933,3087,3258,3395,3405,3434,3444,3458,3460,3504,3517,3535,3547,3559,3625,3650,3842,3888,3957,4023,4034,4053,4070,4319,4412,4449,4456,4571,4586,4785,4828,4833],"cardiovascular":[11,1253,1565,1584,2561,2591,2625,2693,2727,3107,3118,3164,3523,3794,3802,3862,4590,4958,4974],"(CV)":[12],"disease":[13,896,1701],"(CVD).1":[14],"In":[15,322,423,689,844,1130,1353,1462,1677,2047,2408,2498,2520,3832,3903,4077,4329,4361],"large,":[17],"prospective,":[18],"cohort":[19,432,1466],"study":[20,1083,1191,1227,1331,1456,4138],"of":[21,25,28,38,56,72,80,98,146,150,202,207,217,262,298,310,327,381,442,491,508,512,538,590,607,619,644,675,701,793,814,818,827,879,889,907,928,937,940,963,1014,1019,1048,1061,1068,1081,1091,1119,1148,1173,1190,1358,1388,1473,1481,1495,1528,1606,1637,1661,1679,1682,1694,1713,1728,1735,1757,1792,1831,1911,1927,1999,2008,2036,2054,2080,2089,2096,2118,2153,2192,2272,2288,2360,2369,2397,2415,2441,2513,2531,2570,2795,2810,2830,2881,2896,2925,2943,2984,2992,2996,3011,3017,3055,3067,3136,3181,3250,3268,3303,3326,3354,3401,3591,3658,3673,3749,3772,3790,3811,3845,3881,3899,3905,3909,3913,3938,3963,3992,4025,4030,4085,4095,4109,4114,4161,4185,4201,4204,4211,4234,4260,4266,4276,4291,4298,4342,4409,4417,4427,4462,4468,4503,4522,4562,4589,4595,4674,4683,4690,4703,4708,4712,4738,4741,4747,5054,5068,5071,5077,5081],"individuals":[22],"\u226530":[23],"years":[24,37],"age,":[26],"18%":[27],"patients":[29,81,220,353,369,608,654,713,756,892,1069,1076,1181,1417,1496,1524,1669,1719,2450,2483,2515,2533,2906,2927,2993,3110,3259,3361,3541,3607,3624,3631,3646,3694,3917,4090,4286,4355,4450,4470,4528],"with":[30,54,82,115,221,354,378,421,455,535,586,609,650,655,710,714,786,842,867,893,949,957,995,999,1040,1163,1182,1337,1345,1350,1365,1385,1394,1409,1418,1446,1497,1525,1722,1849,1853,1914,1993,2210,2214,2275,2354,2504,2797,2856,2902,2907,3111,3152,3260,3362,3542,3608,3632,3647,3768,3838,3940,4067,4075,4356,4421,4451,4458],"developed":[32,290],"incident":[33],"CVD":[34,57,231,659,718,1105,1168,1421,1631,2464,2486,2539,2911,3461,3543,3610,3633,3659,4071],"over":[35,3994],"5.5":[36],"follow-up.2":[39],"Diabetes":[40,866,1741,2102,2853,2919,3528,3781,3846,4968],"in":[41,52,69,136,159,163,219,269,344,414,480,495,542,550,581,653,683,712,729,755,777,837,865,885,918,925,984,997,1093,1117,1169,1175,1180,1212,1225,1415,1425,1452,1457,1491,1522,1633,1640,1699,1717,1789,1816,1833,1851,1925,1963,2010,2086,2150,2177,2194,2212,2286,2324,2371,2447,2452,2480,2508,2550,2574,2582,2799,2818,2850,2905,2977,3014,3044,3073,3103,3109,3312,3318,3360,3380,3398,3448,3606,3766,3836,3871,3921,3936,3949,3968,3985,4003,4057,4128,4140,4192,4225,4354,4465,4511,4555,4592,4835,4948,4973,5061],"itself":[42],"increases":[43],"mortality":[44,48,751,832,971,1896,1913,2257,2274],"risk,":[45,78,3004,3024,3492],"but":[46,1074,1138,1162,2021,2069,2382,2430,3126,3376,3437,4121,4369],"the":[47,147,164,181,190,200,256,272,295,325,345,382,439,465,509,587,603,629,633,690,697,730,737,778,791,794,819,828,838,859,875,905,919,935,938,964,985,1012,1015,1041,1046,1082,1088,1094,1100,1113,1126,1144,1170,1200,1213,1405,1426,1440,1453,1471,1488,1492,1529,1560,1593,1657,1662,1680,1700,2006,2038,2051,2367,2399,2412,2453,2499,2521,2558,2566,2671,2773,2793,2800,2805,2811,2827,2837,2861,2867,2878,2894,2918,2926,2930,2947,2997,3015,3018,3301,3323,3381,3402,3412,3428,3475,3570,3677,3714,3718,3742,3750,3769,3834,3839,3843,3865,3878,3886,3896,3906,4004,4107,4159,4183,4209,4212,4247,4258,4296,4308,4313,4330,4333,4340,4374,4413,4446,4466,4504,4559,4587,4709,4825,4844,4889,5069,5072,5078],"rate":[49,1116,2079,2440,3353],"nearly":[50],"doubles":[51],"combination":[53],"manifestations":[55],"[e.g.":[58,3484],"myocardial":[59,1207,1287,1797,1948,1974,2158,2309,2335,2638,2740],"infarction":[60],"(MI)":[61],"or":[62,226,241,660,706,802,945,1024,1153,1209,1578,1720,1943,1946,1966,1983,2082,2304,2307,2327,2344,2443,2458,2579,2912,2963,2972,3048,3277,3356,3369,3597,3655,4174,4188,4268,4390,4415,4457,5076],"stroke],":[63],"translating":[64],"into":[65,364,474,574,3058,3687],"an":[66,154,307,436,1363,1540,2024,2385,2938,2969,3273,3564,3651,3663,3777,4058,4288,4681,4688],"estimated":[67,155],"reduction":[68,728,1047,1681,2573,3463],"life":[70,4267],"expectancy":[71],"12":[73],"years.3":[74],"Despite":[75,487,1085,1656],"this":[76,137,140,1086,1131,1644,2496,2978,4122,4381,5062],"alarming":[77],"30\u201350%":[79],"do":[84,3309],"not":[85,834,1028,1141,1544,1559,1800,1923,2161,2284,2488,2645,2747,3440,3946,4367,4384,4472,5065],"meet":[86,3216],"guideline-recommended":[87],"treatment":[88,129,141,820,3020,3256,3715,3806,3901,4213,4414],"goals":[89,3180],"managing":[91],"CV":[92,208,243,296,313,328,337,404,451,540,651,663,679,702,740,748,941,968,1020,1072,1149,1406,1530,1538,1684,2002,2363,2475,2580,2900,3003,3023,3203,3226,3251,3269,3304,3416,3446,3536,3592,3604,3626,3693,3757,4018,4032,4048,4162,4343,4351,4364,4428,4432,4447],"risk.4":[93],",":[94,285,359,460,501,1399,1652,1654,1918,2004,2045,2279,2365,2406,2469,2471,3037,3452,3454,3576,3578],"5":[95],"Only":[96,3286],"14%":[97],"NHANES":[99],"(National":[100],"Health":[101,4829,4837],"and":[102,106,122,167,187,189,197,211,276,280,320,333,350,356,361,385,406,408,445,477,530,566,595,605,611,613,635,657,716,749,862,877,897,923,969,991,1050,1219,1361,1372,1381,1419,1477,1487,1503,1512,1686,1787,1829,1845,1985,2001,2040,2059,2148,2190,2206,2346,2362,2401,2420,2540,2864,2886,2909,3002,3005,3031,3085,3092,3097,3105,3134,3150,3155,3193,3220,3236,3239,3292,3331,3373,3411,3498,3554,3572,3595,3611,3628,3708,3730,3782,3797,3805,3828,3861,3864,3952,3961,4106,4132,4215,4243,4255,4285,4317,4322,4346,4358,4377,4430,4481,4494,4507,4513,4532,4537,4576,4581,4617,4619,4625,4629,4632,4644,4664,4672,4719,4723,4753,4788,4822,4839,4843,4863,4920,4944,4956,4988,4992,5056],"Nutrition":[103],"Examination":[104],"Survey)":[105,113],"BRFSS":[107],"(Behavioral":[108],"Risk":[109],"Factor":[110],"Surveillance":[111],"System":[112],"participants":[114],"achieved":[117,3894],"HbA1c,":[118],"blood":[119,1310,3210,3489],"pressure,":[120,3490],"LDL-cholesterol,":[121],"non-smoking":[123],"goals.4":[124],"Accordingly,":[125,2941],"providing":[126],"optimal":[127,3132,3589,4501],"cardioprotective":[128,493,1573,2883],"strategies":[130],"remains":[131,498,1611],"major":[133,311,450,1683,3449,3532,3934,4349],"unmet":[134],"need":[135,1689,3243,3956],"population.":[138,2586],"Addressing":[139],"gap":[142],"imperative":[144],"because":[145,3400],"burdensome":[148],"prevalence":[149],"T2DM,":[151,898,1526,3175,3261],"which":[152,1542,1618,3891,4168,4219],"impacts":[153],"58":[156,2523,2560,2869,3038],"million":[157,162,174],"people":[158,3939],"Europe,":[160,4362],"46":[161,2046,2407],"United":[165,273,2801,4331],"States,":[166,4332],"it":[168,1139,2022,2070,2383,2431,3343],"expected":[170],"to":[171,215,254,291,324,469,532,553,557,568,583,601,614,641,721,758,812,887,988,1007,1034,1099,1136,1518,1563,1613,1690,1707,1842,2203,2946,2967,3070,3076,3079,3116,3131,3185,3189,3215,3244,3247,3263,3408,3442,3618,3629,3643,3691,3717,3725,3807,3820,3855,3877,3979,4010,4079,4125,4137,4152,4156,4167,4217,4223,4249,4281,4373,4394,4499,4518,4525,4531,4579,4700],"reach":[172],"629":[173],"globally":[175],"by":[176,271,736,855,975,1045,1112,1439,1579,1649,3123,3201,3271,3425,3563,3676,3737,3895,4046,4312,4388,4558],"2045.6":[177],"Among":[178],"glucose-lowering":[179,301,572,620,676,1729,2090,3222,3599,3665,4027],"therapies,":[180,4245,4437],"sodium-glucose":[182,1836,2197,3173],"cotransporter-2":[183],"(SGLT-2)":[184],"inhibitors":[185,444,1431,1451,1502,2885,3288,3421,4187],"empagliflozin":[186,694,2665,2767],"canagliflozin":[188,788,839,850,880],"glucagon-like":[191,1766,2127,3169],"peptide-1":[192],"(GLP-1)":[193],"receptor":[194,387,913,980,1475,1505,2601,2642,2703,2744,2888,2954,2975,3279,3295,4190],"agonists":[195,1476,1506,2889,3296,4191],"liraglutide":[196,915,2679,2781],"semaglutide":[198,334,351,1031,1513,4323],"reduced":[199,696,754,790,836,934,974,1479,2050,2411,3322],"primary":[204,596,698,795,1017,1127,1145,1201,1561,1931,2292,2567,2964,3032,3093,3237,3619,3679,3720,3922,3950,3969,3980,4489],"composite":[205,699,731,796,829,939,965,1016,1128,1146,1202,2568],"outcome":[206,244,700,1147,1203,1490,1932,2293,2476,2562,2592,2694,3450,3983,4448,4959,4975],"death,":[209,703,799,942,1021,1150,1205,1687,1939,2300],"MI,":[210,705,801,944,1023,1152,1286,1484,1796,2058,2157,2419,2637,2739,3330],"stroke":[212,708,947,1049,2060,2081,2421,2442,3332,3355,3368],"when":[213,453,719,810,883,1392],"added":[214,720,811],"standard":[216,722,813,888,950,1008,1035],"care":[218,563,597,606,890,951,1009,1036,2965,3033,3094,3139,3238,3620,3680,3721,3813,3914,3923,3929,3951,3965,4283,4490],"T2DM":[222,355,610,656,715,1416,1498,2798,2908,3648,3986,4115,4357,4422,4452],"who":[223,2803,2928,3622],"already":[224,3467,3762,3849],"had":[225],"were":[227,252,289,752,972,1432,1499,2459,2936,2950,2957],"at":[228,661,1422,1602,2460,3668,3826,4424,4453],"(Supplementary":[232,483,742,952,1052,4324],"material":[233,484,685,743,806,953,1053,4325],"online,Table":[234,485],"S1).":[235,746,1056],"More":[236,4006],"than":[237,2960,4073],"20":[238],"prospective":[239],"completed":[240,666],"ongoing":[242,377],"trials":[245,618,668,1101,2491,2593,2695,3984,4043,4050,4062,4173,4177,4205],"(CVOTs)":[246],"involving":[247],"approximately":[248,2511],"190":[249],"000":[250],"participants7":[251],"initiated":[253,3122,3776],"fulfil":[255],"regulatory":[257,528],"requirements":[258,288],"clinical":[260,496,575,617,872,1936,2297,2879,3059,3081,4119,4375,4407,4946],"investigation":[261,4084,4408],"new":[263,440,1386,3019,3056,3866,4055,4061,4261,4403],"drugs":[264,621,677,3754,4038,4066],"issued":[268,4401],"2008":[270],"States":[274,2802],"Food":[275],"Drug":[277,4731],"Administration":[278],"(FDA)":[279],"European":[281,510,1755,2116,3770,3840,4314,4560,4701,4710,4730,5073,5079],"Medicines":[282,4315],"Agency":[283,4316],"(EMA).8":[284],"9":[286],"The":[287,462,503,544,665,726,816,911,1057,1341,2449,3179,3456,3764,3785,4165,4199,4397,4565,4893,5058],"address":[292],"concerns":[293],"surrounding":[294],"safety":[297,405,878,4049,4378],"some":[299,3293,4235],"oral":[300,3565],"drugs.":[302],"These":[303,397,1401,1552],"studies":[304,398,433,1402,4256],"ruled":[305],"out":[306],"excess":[308],"adverse":[312,3505,4350,4431],"events":[314,1092,1121,1189,1685,3197,3252,3447,3605,4155,4352],"saxagliptin,":[316],"alogliptin,":[317],"sitagliptin,":[318],"lixisenatide,":[319],"exenatide.10":[321],"addition":[323,886,4078],"demonstration":[326,4029],"safety,":[329,1161],"empagliflozin,":[330,348,1509,3290,4320],"canagliflozin,":[331,1510],"liraglutide,":[332,349,1511,3298,4321],"also":[335,411,765,770,1157,1536,2075,2436,3052,3231,3344,3349,3602,3977],"improved":[336,2899],"outcomes.11\u201314":[338],"This":[339,626,3682,4541],"evidence":[340,402,1321,1706,1992,2353,2897,3057,3457,3751,3993,4478],"has":[341,370,899,1332,1543,1646,2890,3775,3848,4246,4399,4471],"been":[342,371,472,900,1437,1545,1647,2043,2404,2891,4474],"incorporated":[343],"labels":[346,4293,4334],"established":[357,658,717,2518,3609,3850,4359,4459],"CVD,15":[358],"16":[360],"prompt":[362],"integration":[363],"management":[365,604,3183,3590,3804,3937,4113],"pathways":[366],"such":[368,1507,1692,3740,4014,4294],"suggested.17":[372],"Several":[373],"large":[374,429,1325,3990],"CVOTs":[375,467,1349,2454,2815,4480],"are":[376,681,1228,1343,2516,2662,2669,2677,2683,2764,2771,2779,2785,2994,3141,3184,3390,3422,3439,3544,3574,3634,3660,3695,3761,3918,3945,4423,4533,5064],"other":[379,393,456,1395,1548,1576,1650,3240,3307,3656,3698],"members":[380],"SGLT-2":[383,443,772,1351,1390,1411,1430,1501,2813,2884,2939,2970,3275,3287,4186],"inhibitor":[384,773,1391,1412,2814,2971,3276],"GLP-1":[386,912,979,1474,1504,2887,2953,2974,3278,3294,4189],"agonist":[388,914,2976,3280],"classes":[389],"as":[390,392,1110,1377,1379,1508,1622,3427,3466,3478,3480,3585,3741,3792,3973,4295],"well":[391,1378,3479],"glucose":[394,457,648,723,1396,1448,1549,1556,1600,1609,3557,3566,4036,4442],"lowering":[395,458,724,1397,1550,1557,4037],"therapies.":[396,1551,4396,4540],"will":[399,410,2492,3025,3787,3868,4134,4149,4206],"provide":[400,2493,3798,4179],"further":[401,3958],"concerning":[403],"efficacy,":[407],"they":[409,3438],"contribute":[412],"data":[413,427,463,1322,1346,2494,2823,2986,3477,4181,4240],"broader":[415],"(i.e.":[416,560,3289,3297],"lower":[417,447,1272,1367,2078,2439,2481,3225,3352,4086,4141,4193],"risk)":[418],"patient":[419,2585,3074,3508,4195,4269],"populations":[420,1192,4088,4196],"T2DM.":[422,3612],"addition,":[424,3833],"real":[425,1454],"world":[426,1320],"from":[428,464,632,1323,1347,1598,1941,1973,2302,2334,2557,2590,2663,2670,2678,2684,2692,2765,2772,2780,2786,2824,2917,4479,4545,4602,4621,4640,4648,4698,4760,4770,4776,4790,4808,4824,4853,4888,4911,4930,4966,4999,5012,5035],"international":[430],"pharmacoepidemiology":[431],"have":[434,468,670,1436,1670,2042,2403,2534,2542,3100,3932,3987,4515,4529],"shown":[435,682,1384,1438,1546,2661,2668,2676,2682,2763,2770,2778,2784,3078],"association":[437,1364],"between":[438,1470,2999,3028,3089,4103,4307,4485,4574],"initiation":[441,1387],"outcomes":[452,680,2901,4271],"compared":[454,709,841,948,1393,4074],"drugs.18":[459,1398],"19":[461,1400],"reported":[466,4270],"different":[470,1339,1711],"degrees":[471],"integrated":[473,3686],"both":[475,2037,2398,3099,3153,4441],"cardiology":[478,4512],"guidelines":[479,582,3550,3857],"several":[481],"countries":[482],"S2).":[486],"these":[488,492,1075,1534,1568,1695,2903,3068,3616,3674,4080,4202,4395,4463,4535],"recommendations,":[489],"adoption":[490],"therapies":[494,573,1665,1696,3077,3223,3472,3600,3700,4139,4464],"practice":[497],"relatively":[499,3996],"low.20":[500],"21":[502],"Cardiovascular":[504,781,929,990,1062,1188,1221,1359,1444,1745,1793,1844,2106,2154,2205,2502,2527,2873,3783,3982,4549],"Round":[505,4550],"Table":[506,687,745,808,955,1055,4327,4551],"(CRT)":[507,4552],"Society":[511,1756,2117,4561,4702,4711,4737,5080],"Cardiology":[513,3774,4563],"(ESC)":[514],"strategic":[517,4569,4584],"forum":[518,4570],"high-level":[520,4572],"dialogue":[521,4573],"that":[522,646,669,774,1102,1404,1555,1709,2923,2988,3042,3224,3601,3638,3755,4000],"brings":[523],"together":[524],"ESC":[525,545,577,3743,3765,3835,4577],"leadership,":[526],"academia,":[527],"agencies,":[529],"industry":[531,4575],"facilitate":[533],"collaboration":[534,3027,3088,3837],"goal":[537,3257],"improving":[539],"health":[541,3045,3812,3964,4282,4591],"Europe.":[543,4593],"CRT":[546,4566],"convened":[547],"workshop":[549,634,4553],"February":[551,4556],"2018":[552,2548,4557],"discuss":[554,4582],"how:":[555],"best":[556],"empower":[558],"clinicians":[559,585],"general":[561,1493,3399],"practitioners/primary":[562],"physicians,":[564,4491],"endocrinologists,":[565,3029,3091,4486],"cardiologists)":[567],"integrate":[569],"recent":[570,1184,2820,3364],"evidence-based":[571,591,1664,2882,3274,3664,3699,3943,4436],"practice;":[576],"can":[578,599,1514,3120,3198,4439],"promote":[579],"evolution":[580],"assist":[584],"practical":[588],"implementation":[589,643,3641,3672,4502],"therapies;":[592],"cardiology,":[593],"endocrinology,":[594],"disciplines":[598],"collaborate":[600],"improve":[602,642,1519,1537,3080,3640,4118,4440],"CVD;":[612],"design":[615],"future":[616,4588],"based":[622,903,1460,3473],"on":[623,678,739,904,1167,1583,1630,1675,2526,2872,3431,3474,3486,3662,3697,3780,3801,3858,3885,4182,4208,4263,4406],"accumulating":[624],"knowledge.":[625],"manuscript":[627],"summarizes":[628],"key":[630,4583],"outputs":[631],"describes":[636],"concepts":[637],"around":[638],"collaborative":[639],"steps":[640],"therapy":[645,1625,3518,3727],"combines":[647],"control":[649,1521,1610,1674,1821,2182,3206,3230,3397,3584,4233,4443],"benefit":[652,854,1407,4033,4069],"high":[662,2461,3284,3403,4425,4454],"risk.":[664,1566,3758],"randomized":[667,757,1348,1820,2181,4041,4175],"demonstrated":[671,1111,1671,2076,2437,3350],"beneficial":[673],"effect":[674,738,821,1042,1166,1541,1629,1645,3494,4214],"Supplementary":[684,805],"online,":[686,744,807,954,1054,4326],"S1.":[688],"EMPA-REG":[691,1217,2840,2934,4951],"OUTCOME":[692,2935],"trial,":[693,873,2510,2529],"significantly":[695,753,766,789,835,973,1142],"non-fatal":[704,707,800,803,943,946,1022,1025,1151,1154,1206,1210,1947,2057,2308,2418,3329],"placebo":[711,882,1114,1193,2085,2446,3359,3443],"therapy.14":[725],"endpoint":[732,797,1018,2053,2414,2569,3325],"was":[733,764,775,822,833,916,982,1005,1032,1097,1134,1383,2012,2373,2816,4543],"driven":[734,1044],"primarily":[735],"death":[741,1940,1972,2301,2333,2581,4344,4429],"Both":[747,967],"all-cause":[750,970,1895,1989,2055,2256,2350,2416,3327],"empagliflozin.":[759],"Notably,":[760],"heart":[761,848,1241,1265,1374,1773,1951,2134,2312,2577],"failure":[762,1375,2578],"hospitalization":[763,846,1376,2575],"reduced.":[767],"Canagliflozin":[768,1744,2105],"tested":[776,4127],"CANVAS":[779,1214,2862],"(Canagliflozin":[780,861],"Assessment":[782,1746,2107],"Study)":[783],"Program.13":[784],"Compared":[785],"placebo,":[787,1137],"(CV":[798],"stroke,":[804,1382,1953,1976,2314,2337],"S1)":[809],"care.":[815,3970,3981],"magnitude":[817],"similar":[823,1098,2474,2945],"across":[824,960,3143],"all":[825,961,1370,1428,1515,2456,3144,3645,4035],"components":[826,962],"endpoint.":[830,966],"All-cause":[831],"arm":[840],"placebo.":[843],"reducing":[845,1011,3022,3445,4539],"failure,":[849,1952,1955,2313,2316],"showed":[851,1626,2922],"possible":[853],"exploratory":[856],"analysis.":[857],"Interestingly,":[858,2792],"CREDENCE":[860],"Renal":[863,4724],"Events":[864,2503],"Established":[868],"Nephropathy":[869],"Clinical":[870,1814,2175,3316,4506,4716,4725],"Evaluation)":[871],"evaluating":[874],"efficacy":[876,909,1921,2282,4376],"vs.":[881,1873,2084,2234,2445,3358],"used":[884,1224,4311],"chronic":[894,1244],"kidney":[895,1245],"stopped":[901],"early":[902],"achievement":[906],"pre-specified":[908],"criteria.22":[910],"studied":[917],"LEADER":[920,2948],"(Liraglutide":[921],"Effect":[922,1786,2147,2525,2871],"Action":[924,1788,2149],"Diabetes:":[926,1790,2151],"Evaluation":[927,1791,2152],"Outcome":[930,1794,2155],"Results)":[931],"trial.12":[932],"Liraglutide":[933,1785,2146],"S1),":[956],"consistent":[958,1344,1414],"reductions":[959],"liraglutide.":[976],"Semaglutide,":[977],"another":[978],"agonist,":[981],"evaluated":[983],"SUSTAIN-6":[986],"(Trial":[987],"Evaluate":[989,1843,2204],"Other":[992,1846,2207],"Long-Term":[993,1847,2208],"Outcomes":[994,1445,1828,1848,2189,2209,2846],"Semaglutide":[996,1004,1850,2211],"Subjects":[998,1852,2213],"Diabetes)":[1002,2509],"trial.11":[1003],"non-inferior":[1006],"stroke.":[1026],"While":[1027],"formally":[1029],"pre-specified,":[1030],"superior":[1033,1165,3441],"(P":[1037],"=":[1038,1870,2067,2231,2428,3341],"0.02),":[1039],"mainly":[1043],"MI":[1051,1380,1903,2000,2009,2083,2264,2361,2370,2444,3357],"EXSCEL":[1058,1095,1118],"(Exenatide":[1059],"Study":[1060,3844],"Event":[1063],"Lowering)":[1064],"trial":[1065,4228,4236],"permitted":[1066],"enrolment":[1067],"without":[1070,1420,2484,2517,4091],"prior":[1071],"events,":[1073,3305],"accounted":[1077],"only":[1079,1599,1632],"27%":[1080],"population.23":[1084],"allowance,":[1087],"overall":[1089],"incidence":[1090],"population":[1096,1326,1494,2829,2949],"required":[1103,4045,4136],"pre-existing":[1104,2910,4092],"inclusion":[1107],"(Figure":[1108,3035],"1),":[1109],"event":[1115,1194],"40":[1120],"per":[1122,1196],"1000":[1123,1197],"patient-year":[1124,1198],"endpoint.23":[1129],"study,":[1132],"exenatide":[1133,2685,2787],"noninferior":[1135],"did":[1140],"reduce":[1143,1564,1614,3117,3186,3300,3603,3756,4339,4348],"stroke.23":[1155],"Previously,":[1156],"lixisenatide":[1158],"confirmed":[1159,1924,2023,2285,2384],"its":[1160],"no":[1164,1705,3377],"ELIXA":[1171],"(Evaluation":[1172],"Lixisenatide":[1174],"Acute":[1176],"Coronary":[1177],"Syndrome)":[1178],"Trial":[1179,1815,1841,2176,2202,3317],"acute":[1185,1483,3158,3652],"coronary":[1186,1231,1236,1240,1300,2610,2615,2712,2717,3159,3653],"syndrome.24":[1187],"rates":[1195],"(cardiovascular":[1204],"infarction,":[1208,1949,1975,2310,2336],"stroke)":[1211],"Program,":[1215],"LEADER,":[1216,1784,2145,4953],"OUTCOME,":[1218,2841,4952],"SUSTAIN-6.":[1220],"definitions":[1223],"each":[1226,2809],"shown.":[1229],"CABG,":[1230,2609,2711],"artery":[1232,1237,1296,2611,2616,2649,2713,2718,2751],"bypass":[1233,2612,2714],"graft;":[1234,2613,2715],"CAD,":[1235,2614,2716],"disease;":[1238,1242,1246,1254,1297,1305,1805,2166,2617,2626,2650,2719,2728,2752,3165,3524],"CHD,":[1239],"CKD,":[1243],"CV,":[1247,2622,2724,3161,3520],"cardiovascular;":[1248,2623,2725,3162,3521],"CVA,":[1249],"cerebrovascular":[1250,1485],"accident;":[1251],"CVD,":[1252,1373,1607,2624,2726,3163,3522],"DM,":[1255,1751,2112,3525],"mellitus;":[1257,1753,2114],"ECG,":[1258],"electrocardiogram;":[1259],"HDL-C,":[1260],"high-density":[1261,1770,2131],"lipoprotein":[1262],"cholesterol;":[1263,1859,2220],"HF,":[1264,1772,2133],"failure;":[1266,1774,2135],"hosp,":[1267],"hospitalization;":[1268],"HTN,":[1269,2631,2733],"hypertension;":[1270],"LE,":[1271],"extremity;":[1273],"LVH,":[1274,2633,2735],"left":[1275,1279,1282,2634,2736],"ventricular":[1276,1283,2635,2737],"hypertrophy;":[1277,2636,2738],"LV,":[1278],"ventricular;":[1280],"LVSD,":[1281],"systolic":[1284,1309],"dysfunction;":[1285],"infarction;":[1288,1798,2159,2639,2741],"NYHA,":[1289],"New":[1290],"York":[1291],"Heart":[1292,1737,2098,4631,4705,4735,5074],"Association;":[1293,1738,1742,2099,2103],"PAD,":[1294,1802,2163,2647,2749],"peripheral":[1295,1303,1803,1977,2164,2338,2648,2750],"PCI,":[1298],"percutaneous":[1299],"intervention;":[1301],"PVD,":[1302],"vascular":[1304,1978,2339],"revasc,":[1306],"revascularization;":[1307],"SBP,":[1308],"pressure;":[1311],"TIA,":[1312,2656,2758],"transient":[1313,2657,2759,3370],"ischaemic":[1314,2658,2760,3367,3371],"attack;":[1315],"UA,":[1316],"unstable":[1317],"angina.":[1318],"Real":[1319],"comparative":[1327],"effectiveness":[1328,4160],"propensity":[1329],"matched":[1330],"provided":[1333],"complementary":[1334,3262],"data,":[1335],"however,":[1336,1643],"methodology.":[1340],"results":[1342,1435,1922,2283,2556],"inhibitors.":[1352],"CVD-REAL":[1354,1427],"(The":[1355],"Comparative":[1356],"Effectiveness":[1357],"Outcomes)":[1360],"CVD-REAL-2":[1362],"cause":[1371],"suggest":[1403,1554],"associated":[1408],"baseline.":[1423],"Noteworthy,":[1424],"available":[1429,3476],"evaluated.":[1433],"Similar":[1434],"EASEL":[1441],"(Evidence":[1442],"Sodium":[1447],"co-transporter":[1449],"world)":[1455],"US":[1459],"population.25":[1461],"similar,":[1463],"smaller":[1464],"retrospective":[1465],"studies,":[1467],"significant":[1468],"associations":[1469],"use":[1472,3410],"mortality,":[1482,2056,2417,3328],"accidents,":[1486],"combined":[1489],"observed.26\u201329":[1500],"be":[1516,3121,3199,3282,3685,3869,3893,4021,4044,4051,4063,4126,4135,4150,4221,4385],"prescribed":[1517,2937,2951],"glycaemic":[1520,1673,3229,3264,3396,3435,3583],"adult":[1523],"irrespective":[1527],"profile.":[1532],"Moreover,":[1533],"agents":[1535,1569,2904,3069,3308,4262],"outcomes,":[1539,4120],"findings":[1553],"mechanism":[1562],"Rather,":[1567],"likely":[1570,2959],"exert":[1571],"their":[1572,1580,3008,3065,3409,3415],"effects":[1574,1582,2477,3485,4184],"through":[1575,3815],"mechanisms30":[1577],"ancillary":[1581,3481],"factors":[1586,2537],"(Table":[1587,2465,3496,3511],"1":[1588],"31":[1589],"\u2013":[1590],"50).":[1591],"Thus,":[1592,3266],"focus":[1594],"should":[1595,1715,3063,3281,3470,3539,3581,3614,3711],"shift":[1596],"away":[1597],"control,":[1601,3212,3436],"least":[1603],"prevention":[1605,3249,4163,4416],"although":[1608],"important":[1612,3874,4289],"microvascular":[1615,3194,3233],"complications.":[1616],"Metformin,":[1617],"uniformly":[1620],"recommended":[1621,3218],"first":[1623,3429],"line":[1624],"positive":[1628,2555],"small":[1635],"subgroup":[1636],"obese":[1638],"subjects":[1639],"UKPDS":[1641,1868,1920,2229,2281],"34,41":[1642],"questioned":[1648],"evidence.34":[1651],"35":[1653],"51":[1655],"observed":[1658],"benefits,":[1659],"prescription":[1660],"novel,":[1663],"delayed":[1667],"until":[1668],"inadequate":[1672],"metformin.":[1676],"view":[1678,3904],"physicians":[1688,2966,3034,3242,3621,4389,4438],"consider":[1691],"prioritization":[1693],"much":[1697],"earlier":[1698],"trajectory.":[1702],"There":[1703],"indicate":[1708],"type":[1712],"response":[1714],"occur":[1716,2479],"treatment-na\u00efve":[1718],"those":[1721,2944,5067],"HbA1c":[1723,3553,3571],"<7%":[1724],"(53":[1725],"mmol/mol).":[1726],"Comparison":[1727,2088],"drug":[1730,2091,3482],"classes31\u201350":[1731,2092],"ACC/AHA,":[1732,2093],"American":[1733,1740,2094,2101],"College":[1734,2095],"Cardiology/American":[1736,2097],"ADA,":[1739,2100],"CANVAS,":[1743,2104],"Study;":[1747,2108],"DPP4,":[1748,2109],"dipeptidyl":[1749,2110,2629,2731],"peptidase-4;":[1750,2111,2630,2732],"ESC,":[1754,2115],"Cardiology;":[1758,2119],"GI,":[1759,2120],"gastrointestinal;":[1760,2121],"GIP,":[1761,2122],"glucose-dependent":[1762,2123],"insulinotrophic":[1763,2124],"polypeptide;":[1764,2125],"GLP-1,":[1765,2126,3168],"peptide":[1767,2128,3170],"1;":[1768,2129,3171],"HDL,":[1769,2130],"lipoprotein;":[1771,1783,2132,2144],"IRIS,":[1775,2136],"insulin":[1776,2137,3374],"resistance":[1777,2138,3375],"intervention":[1778,2139],"after":[1779,2140,3386,3432],"stroke;":[1780,2141],"LDL,":[1781,2142],"low-density":[1782,2143],"Results;":[1795,2156],"NR,":[1799,2160,2644,2746],"reported;":[1801,2162,2646,2748],"arterial":[1804,2165],"PPAR,":[1806,2167],"peroxisome":[1807,2168],"proliferator":[1808,2169],"activated":[1809,2170],"receptor;":[1810,2171],"PROactive,":[1811,2048,2172,2409,4949],"Prospective":[1812,2173],"Pioglitazone":[1813,2074,2174,2435,3315,3348],"Macrovascular":[1817,2178,3196,3319],"Events;":[1818,2179],"RCT,":[1819,2180],"trial;":[1822,2183],"RECORD,":[1823,2184],"Rosiglitazone":[1824,2185],"Evaluated":[1825,2186],"Cardiac":[1827,2188],"Regulation":[1830,2191],"Glycaemia":[1832,2193],"Diabetes;":[1834,1856,2195,2217],"SGLT-2,":[1835,2196,3172],"cotransporter-2;":[1837,2198,3174],"SU,":[1838,2199],"sulfonylurea;":[1839,2200],"SUSTAIN-6,":[1840,2201],"TC,":[1857,2218],"total":[1858,2219,2672,2774],"TG,":[1860,2221],"triglycerides;":[1861,2222],"\u2191,":[1862,2223],"increase;":[1863,2224],"\u2193,":[1864,2225],"decrease;":[1865,2226],"\u2194,":[1866,2227],"neutral.":[1867,2228],"(n":[1869,2230],"753)41:":[1871,2232],"metformin":[1872,1915,2233,2276,3433,3459],"conventional":[1874,2235],"(i)":[1875,1934,2236,2295],"any":[1876,2237],"DM-related":[1877,1887,2238,2248],"endpointb":[1878,2239],"[HR":[1879,2240],"0.68,":[1880,2241],"95%":[1881,1891,1899,1906,2018,2030,2063,2242,2252,2260,2267,2379,2391,2424,3336]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2904596955","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":15}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2018-12-22T00:00:00"}
